ATE388186T1 - Polyalkylenglykol derivat - Google Patents

Polyalkylenglykol derivat

Info

Publication number
ATE388186T1
ATE388186T1 AT03811545T AT03811545T ATE388186T1 AT E388186 T1 ATE388186 T1 AT E388186T1 AT 03811545 T AT03811545 T AT 03811545T AT 03811545 T AT03811545 T AT 03811545T AT E388186 T1 ATE388186 T1 AT E388186T1
Authority
AT
Austria
Prior art keywords
formula
polyalkylene glycol
derivative
glycol derivative
hrd
Prior art date
Application number
AT03811545T
Other languages
German (de)
English (en)
Inventor
Ken-Ichiro Nakamoto
Shunsuke Ohhashi
Yuji Yamamoto
Kenji Sakanoue
Chika Itoh
Tohru Yasukohchi
Original Assignee
Nof Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nof Corp filed Critical Nof Corp
Application granted granted Critical
Publication of ATE388186T1 publication Critical patent/ATE388186T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C08G65/2603—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen
    • C08G65/2606—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen containing hydroxyl groups
    • C08G65/2609—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen containing hydroxyl groups containing aliphatic hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polyethers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT03811545T 2002-11-20 2003-11-20 Polyalkylenglykol derivat ATE388186T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002337113 2002-11-20

Publications (1)

Publication Number Publication Date
ATE388186T1 true ATE388186T1 (de) 2008-03-15

Family

ID=32321831

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03811545T ATE388186T1 (de) 2002-11-20 2003-11-20 Polyalkylenglykol derivat

Country Status (11)

Country Link
US (4) US20050058620A1 (enExample)
EP (3) EP1911788B1 (enExample)
JP (2) JP4412461B2 (enExample)
KR (1) KR100988733B1 (enExample)
CN (1) CN100402580C (enExample)
AT (1) ATE388186T1 (enExample)
AU (1) AU2003302031A1 (enExample)
CA (1) CA2502948C (enExample)
DE (1) DE60319568T2 (enExample)
IL (2) IL168238A (enExample)
WO (1) WO2004046222A1 (enExample)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7157277B2 (en) 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7179617B2 (en) * 2001-10-10 2007-02-20 Neose Technologies, Inc. Factor IX: remolding and glycoconjugation of Factor IX
MXPA04012496A (es) 2002-06-21 2005-09-12 Novo Nordisk Healthcare Ag Glicoformos del factor vii pegilados.
JP4412461B2 (ja) * 2002-11-20 2010-02-10 日油株式会社 修飾された生体関連物質、その製造方法および中間体
US8003117B2 (en) * 2002-11-20 2011-08-23 Nof Corporation Polyalkylene glycol derivative and modified bio-related substance
US8828373B2 (en) * 2002-11-20 2014-09-09 Nof Corporation Polyalkylene glycol derivative and modified bio-related substance
US20040136952A1 (en) * 2002-12-26 2004-07-15 Mountain View Pharmaceuticals, Inc. Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity
JP5207590B2 (ja) 2002-12-26 2013-06-12 マウンテン ビュー ファーマシューティカルズ，インコーポレイテッド 増強された生物学的能力を有するインターフェロン−βのポリマー結合体
US7432331B2 (en) 2002-12-31 2008-10-07 Nektar Therapeutics Al, Corporation Hydrolytically stable maleimide-terminated polymers
CN102212019B (zh) 2003-03-14 2015-05-27 蔚所番有限公司 支化水溶性聚合物及其缀合物
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
MXPA05010773A (es) 2003-04-09 2005-12-12 Neose Technologies Inc Metodos de glicopegilacion y proteinas/peptidos producidos por los metodos.
ES2380093T3 (es) 2003-05-09 2012-05-08 Biogenerix Ag Composiciones y métodos para la preparación de mutantes de glucosilación de la hormona del crecimiento humana
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
CA2536912C (en) 2003-08-27 2015-03-31 Eyetech Pharmaceuticals, Inc. Combination therapy for the treatment of ocular neovascular disorders
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
WO2005070138A2 (en) 2004-01-08 2005-08-04 Neose Technologies, Inc. O-linked glycosylation of peptides
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
CA2577999A1 (en) * 2004-08-31 2006-03-09 Rory F. Finn Glycerol branched polyethylene glycol human growth hormone conjugates, process for their preparation, and methods of use thereof
US8268967B2 (en) 2004-09-10 2012-09-18 Novo Nordisk A/S Glycopegylated interferon α
US20080176790A1 (en) 2004-10-29 2008-07-24 Defrees Shawn Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf)
JP2008524117A (ja) * 2004-11-12 2008-07-10 バイエル・ヘルスケア・エルエルシー Ｆｖｉｉｉの特定部位の変更
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
WO2006088248A1 (ja) * 2005-02-18 2006-08-24 Nof Corporation ポリオキシアルキレン誘導体
EP1871795A4 (en) 2005-04-08 2010-03-31 Biogenerix Ag COMPOSITIONS AND METHOD FOR PRODUCING GLYCOSYLATION MUTANTS OF A PROTEASE-RESISTANT HUMAN GROWTH HORMONE
EP1891231A4 (en) * 2005-05-25 2011-06-22 Novo Nordisk As GLYCOPEGYLATED FACTOR IX
KR100735784B1 (ko) * 2005-07-20 2007-07-06 재단법인 목암생명공학연구소 인간 과립구콜로니자극인자 변이체 및 이의 화학적 접합물
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
EP1787660A1 (en) * 2005-11-22 2007-05-23 GBF Gesellschaft für Biotechnologische Forschung mbH New adjuvants on the basis of bisacyloxypropylcysteine conjugates and their uses in pharmaceutical compositions
JP2009536963A (ja) * 2006-05-12 2009-10-22 ドン・ア・ファーム・カンパニー・リミテッド ポリエチレングリコール−インターフェロンα結合体
US20080248959A1 (en) 2006-07-21 2008-10-09 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
JP5277599B2 (ja) * 2006-09-29 2013-08-28 日油株式会社 生分解性ポリオキシアルキレン誘導体の製造方法
WO2008057683A2 (en) 2006-10-03 2008-05-15 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
PL2068907T3 (pl) * 2006-10-04 2018-05-30 Novo Nordisk A/S Połączone glicerolem PEGylowane cukry i glikopeptydy
KR101079993B1 (ko) 2006-11-17 2011-11-04 동아제약주식회사 폴리에틸렌글리콜 과립구 콜로니 자극인자 접합체
JP5515224B2 (ja) 2007-02-28 2014-06-11 日油株式会社 多分岐鎖ポリオキシアルキレン誘導体
AU2008237411B2 (en) 2007-04-03 2013-10-03 Ratiopharm Gmbh Methods of treatment using glycopegylated G-CSF
MX2009013259A (es) 2007-06-12 2010-01-25 Novo Nordisk As Proceso mejorado para la produccion de azucares de nucleotidos.
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
EP2626079A3 (en) 2008-02-27 2014-03-05 Novo Nordisk A/S Conjungated factor VIII molecules
US20090246430A1 (en) 2008-03-28 2009-10-01 The Coca-Cola Company Bio-based polyethylene terephthalate polymer and method of making same
WO2010101698A2 (en) 2009-03-03 2010-09-10 The Coca-Cola Company Bio-based polyethylene terephthalate packaging and method of making thereof
JP5418360B2 (ja) * 2009-03-27 2014-02-19 日油株式会社 ポリオキシアルキレン誘導体の製造方法
EP2415800B1 (en) * 2009-03-31 2013-10-16 NOF Corporation Hyperbranched polyoxyalkylene compound and method for producing same
JP5569787B2 (ja) * 2009-03-31 2014-08-13 日油株式会社 高分子量ポリエチレングリコール化合物の精製方法
US8816099B2 (en) 2010-03-31 2014-08-26 Nof Corporation Polyfunctional polyoxyalkylene compound, and producing method and intermediate thereof
WO2011143274A1 (en) 2010-05-10 2011-11-17 Perseid Therapeutics Polypeptide inhibitors of vla4
CN103119055A (zh) 2010-05-17 2013-05-22 塞比克斯公司 聚乙二醇化c肽
US10040761B2 (en) 2010-06-25 2018-08-07 Nof Corporation Branched hetero polyethylene glycol and intermediate
US8933070B2 (en) 2010-07-02 2015-01-13 University Health Network Methods of targeting PTEN mutant diseases and compositions therefor
JP5949037B2 (ja) 2011-03-30 2016-07-06 日油株式会社 末端に複数の水酸基を有するポリオキシエチレン誘導体
US10023693B2 (en) 2013-03-25 2018-07-17 Nof Corporation Hydrophilic polymer derivative having benzylidene acetal linker
EP2980115B1 (en) 2013-03-27 2019-03-06 NOF Corporation Purification method for polyethylene glycol having a single amino group
DK4374873T3 (da) 2013-07-12 2025-11-03 Astellas Us Llc Middel til brug ved behandling eller forebyggelse af oftalmologiske tilstande
CN105622925B (zh) * 2014-03-14 2017-09-12 厦门赛诺邦格生物科技股份有限公司 一种支化聚乙二醇的脂质衍生物及其组成的脂质膜结构体
WO2017043653A1 (ja) * 2015-09-11 2017-03-16 国立大学法人 東京大学 タンパク質を安定化するための化合物
WO2017188372A1 (ja) * 2016-04-28 2017-11-02 日油株式会社 分岐型ポリオキシエチレン化合物およびコンタクトレンズ
JP7042053B2 (ja) * 2016-10-07 2022-03-25 国立大学法人東京工業大学 分岐型ヘテロ単分散ポリエチレングリコール、その製造方法、及びその結合体
JP6935059B2 (ja) 2017-03-30 2021-09-15 日油株式会社 カルボキシル基を一つ有するポリエチレングリコールの精製方法
KR102546103B1 (ko) 2018-03-20 2023-06-21 니치유 가부시키가이샤 분기형 단분산 폴리에틸렌 글리콜, 중간체 및 그 제조 방법
US12441776B2 (en) 2018-11-30 2025-10-14 Eirgen Pharma Ltd. Oxyntomodulin peptide analog formulations
JP7688819B2 (ja) * 2019-12-27 2025-06-05 日油株式会社 ポリエチレングリコール化合物の精製方法
CA3164940A1 (en) 2019-12-27 2021-07-01 Nof Corporation Method for purifying branched polyethylene glycol
WO2023171608A1 (ja) 2022-03-09 2023-09-14 日油株式会社 ポリオキシエチレン誘導体の製造方法、ポリオキシエチレン化合物の定量方法及び分析用ラベル化試薬
CA3250008A1 (en) 2022-03-17 2025-03-04 Nof Corp PROCESS FOR PRODUCING A POLYETHYLENE GLYCOL DERIVATIVE

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025807A1 (de) * 1980-07-08 1982-02-04 Th. Goldschmidt Ag, 4300 Essen Verfahren zur herstellung von polyaethern unter erhalt von mindestens zwei freien hydroxylgruppen am startalkohol
JPH02242823A (ja) * 1989-03-02 1990-09-27 Kiyouseki Seihin Gijutsu Kenkyusho:Kk シアノエチル化ポリエーテルポリオール及び該化合物を有効成分として含有する冷凍機油
US5118448A (en) * 1990-10-19 1992-06-02 Arco Chemical Technology, L.P. Process for producing esterified alkoxylated polyols
JP3218755B2 (ja) * 1992-11-12 2001-10-15 日本油脂株式会社 グリセリンエーテルエステル
JP3067541B2 (ja) * 1994-08-23 2000-07-17 日本油脂株式会社 グリセリンポリアルキレングリコールエーテル誘導体及びその製造方法
JP3921781B2 (ja) * 1998-02-12 2007-05-30 日本油脂株式会社 カルボキシル基含有ポリオキシアルキレン化合物
JP4055250B2 (ja) * 1998-06-15 2008-03-05 日油株式会社 アミノ基含有ポリオキシアルキレン化合物
JP2000230000A (ja) * 1999-02-08 2000-08-22 Hokkaido Univ 一酸化窒素代謝物−ポリオキシアルキレン−ヘモグロビン結合体
JP4123856B2 (ja) * 2001-07-31 2008-07-23 日油株式会社 生体関連物質の修飾剤およびポリオキシアルキレン誘導体の製造方法
JP4412461B2 (ja) 2002-11-20 2010-02-10 日油株式会社 修飾された生体関連物質、その製造方法および中間体
US8003117B2 (en) 2002-11-20 2011-08-23 Nof Corporation Polyalkylene glycol derivative and modified bio-related substance

Also Published As

Publication number Publication date
KR20050083923A (ko) 2005-08-26
JP4412461B2 (ja) 2010-02-10
DE60319568D1 (de) 2008-04-17
JP2009102649A (ja) 2009-05-14
CA2502948C (en) 2013-04-02
CA2502948A1 (en) 2004-06-03
EP1911788A1 (en) 2008-04-16
KR100988733B1 (ko) 2010-10-20
JP5273589B2 (ja) 2013-08-28
EP1911789B1 (en) 2016-04-27
EP1911789A1 (en) 2008-04-16
EP1564236A1 (en) 2005-08-17
DE60319568T2 (de) 2009-04-02
US8034981B2 (en) 2011-10-11
US20110082277A1 (en) 2011-04-07
IL194501A (en) 2011-11-30
AU2003302031A1 (en) 2004-06-15
US20090192320A1 (en) 2009-07-30
CN1714116A (zh) 2005-12-28
US20050058620A1 (en) 2005-03-17
US7524875B2 (en) 2009-04-28
CN100402580C (zh) 2008-07-16
JP2004197077A (ja) 2004-07-15
US20050288490A1 (en) 2005-12-29
EP1911788B1 (en) 2019-03-27
WO2004046222A1 (ja) 2004-06-03
US7851491B2 (en) 2010-12-14
IL168238A (en) 2009-09-22
EP1564236B1 (en) 2008-03-05
EP1564236A4 (en) 2006-01-25

Similar Documents

Publication Publication Date Title
DE60319568D1 (de) Polyalkylenglykol derivat
DE50113704D1 (de) Alkoxysilylgruppenhaltige bindemittel und bindemittelzusammensetzungen, verfahren zu deren herstellung und deren verwendung
KR910700323A (ko) 윤활 조성물
PL366552A1 (en) Acid dyeable polymer compositions
DE69304164D1 (de) Polystyrol-Zusammensetzung
DE69942131D1 (de) Calciumkanalblocker
EP1013749A3 (en) Lubricating compositions
BR0211332B1 (pt) composiÇço poliolefÍnica, processo para a preparaÇço de dita composiÇço, bem como artigo compreendendo a mesma.
CA2133796A1 (en) Fuel compositions and additives therefor
ATE194137T1 (de) Fettamin-derivate von butyliertem hydroxytoluen für den schutz von oberflächen vor physikaler und chemischer degradierung
CA2133270A1 (en) Quaternary Ammonium Hydroxides as Mercaptan Scavengers
ATE549388T1 (de) Additive und schmiermittelformulierungen für verbesserte antioxidanseigenschaften
NO20014100D0 (no) Polyalken alkoholpolyalkoksylater og anvendelse derav i drivstoff og smoremidler
DE50210465D1 (de) Stabilisierte thermoplastische formmassen
EA200300478A1 (ru) Полизамещенные имидазопиридины в качестве ингибиторов желудочной секреции
DE69100346D1 (de) Kältemaschinenöl.
WO2001078162A3 (en) Oligomeric and polymeric oled materials produced via arylation of quinones
DE60025497D1 (de) Polyoxytetramethylenglykol und verfahren zu seiner herstellung
CA2191874A1 (en) Novel processes and intermediates for the preparation of piperazine derivatives
ATE246721T1 (de) Ölzusammensetzung für kältemaschine mit kohlendioxid als kältemittel
KR920012401A (ko) 가솔린 조성물, 및 그에 첨가하는 농축물
KR910021459A (ko) 유성 조성물에 대한 다작용성 점도 지수 개선제로 유용한 신규의 에틸렌 알파-올레핀 중합체 치환된 만니히(Mannich) 염기
WO2002022765A3 (en) Composition
KR910015654A (ko) 디카복실레이트-캡핑된 폴리페닐렌 에테르로부터의 폴리페닐렌 에테르-폴리아미드 조성물
EP1792900A4 (en) DIOXOLANDERIVATE AND METHOD FOR THE PRODUCTION THEREOF

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties